FDA Drug Recalls

Recalls / Class II

Class IID-0343-2022

Product

Meijer allergy relief, Fexofenadine Hydrochloride tablets, 24HR, 1800mg Antihistamine, packaged as a) 15 count bottle, NDC 41250-060-22 UPC 7 60236 18716 5; b) 30 count bottle, NDC 41250-060-39, UPC 7 60236 18717 2; c) 45 count bottle, NDC 41250-060-95, UPC 7 60236 18732 5; Made in the Czech Republic, Distributed by Meijer Distribution Inc, Grand Rapids, MI 49544.

Affected lot / code info
Lot a) 0HE2530, Exp 12/31/2021; 0KE2430, Exp 2/28/2022 b) 0LR0362, Exp 6/30/2022; 1BR0462, Exp 10/31/2022 c) 0FR0460, Exp 2/28/2022

Why it was recalled

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Recalling firm

Firm
Perrigo Company PLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, N/A, Allegan, Michigan 49010-9070

Distribution

Quantity
4536 containers
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2021-07-27
FDA classified
2022-01-05
Posted by FDA
2022-01-12
Terminated
2022-11-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0343-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls